Postbaseline subpopulation analyses: Known to be improper, but
frequently done. Can we fix them?Chairs: Mouna Akacha (Novartis) and Khadija Rantell (MHRA)
- Talk 1 (25min): Björn Bornkamp, Novartis: relevant scientific questions for
drug development
- Talk 2 (25min): Anja Schiel: relevant scientific questions for HTA
Q&A and panel discussion (70min): Speakers + Mats Stensrud (EPFL
Lausanne), Fabrizia Mealli (Uni Florence), Kaspar Rufibach (Roche),
Steve Ruberg (Analytix thinking), Wanje Sun (FDA, virtual), Florian
Klinglmüller (AGES)
…Read more
Less…